Chapter News

Vaccines: contract between European Commission and AstraZeneca now published

Following the renewed request from the European Commission on 27 January 2021, pharmaceutical company AstraZeneca has agreed to publish the redacted contract signed between the two parties on 27 August 2020. The Commission welcomes the company's commitment towards more transparency in its participation in the rollout of the EU Vaccines Strategy. Transparency and accountability are important to help build the trust of European citizens and to make sure that they can rely on the effectiveness and safety of the vaccines purchased at the...

Read more

Chapter News

EUIPO | Payment of fees with credit card: Strong Customer Authentication required

Recently, some of our users have been unable to complete their fee payments with credit/debit cards due to non-compliance with the Strong Customer Authentication (SCA) requirements. To avoid this situation, we recommend that users contact their bank to ensure that their credit/debit cards meet the requirements to complete secure payments. The SCA is a requirement of the second Payment Services Directive (PSD2) within the European Economic Area. It is an authentication process that validates the identity of the user of a payment service or...

Read more

Chapter News

EU Commission puts in place transparency and authorisation mechanism for exports of COVID-19 vaccines

In an effort to ensure timely access to COVID-19 vaccines for all EU citizens and to tackle the current lack of transparency of vaccine exports outside the EU, the Commission has today put in place a measure requiring that such exports are subject to an authorisation by Member States. President of the European Commission Ursula von der Leyen said: “The pandemic is having devastating effects in Europe and all around the world. Protecting the health of our citizens remains our utmost priority, and...

Read more

Chapter News

ESMA consults on changes to CRA supervisory fees

The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, today launches a public consultation on the revision of the Delegated Regulation regarding fees charged to CRAs. The consultation paper contains proposals which ensure that the supervisory fees charged to credit rating agencies (CRAs) reflect the costs of registration, certification and on-going supervision whilst remaining proportionate to CRAs’ turnover. ESMA’s main proposals are to charge: A single registration fee of €45,000; Annual supervisory fees of €20,000 to registered CRAs with annual revenues of between...

Read more

Chapter News

ECB Speech | The sovereign-bank-corporate nexus: A virtuous or a vicious circle?

Speech by Isabel Schnabel, Member of the Executive Board of the ECB, at the LSE conference on “Financial Cycles, Risk, Macroeconomic Causes and Consequences” | Frankfurt am Main, 28 January 2021 | One year after the first cases were reported in Europe, the coronavirus (COVID-19) pandemic continues to take a tragic human toll and to pose enormous challenges to workers, firms, the financial system and policymakers in the euro area. Without the forceful responses of fiscal, monetary and prudential authorities the...

Read more

Member News

MJV | Jobs to be Done: what is it, and how is it used to analyze customers

Have you ever stopped to think about what consumers are really motivated to buy? The Jobs to be Done theory shows us that customers are not looking for a product or service but a solution to a need. What do you look for when you buy running shoes? Something comfortable to work out in seems to be the obvious answer. However, if you apply the Jobs to be Done theory, the answer to the question would probably be: improving health...

Read more

Member News

Trepp | European year-in-review: How the CLO, CRE and CMBS markets fared in 2020

It is undeniable that 2020 was a very challenging year in many respects. The Covid-19 outbreak played the leading role globally. We have seen its impact on the corporate sector and, consequently, on the overall financial markets first hand. Our year-in-review touches upon the main events and trends observed in the European CLO, CRE, and CMBS space throughout 2020. How Did the CLO Market Fare in 2020? The Covid-19 outbreak produced an unprecedented negative shock to businesses globally, with repercussions on both...

Read more

Member News

Vulcan Insight | European Union moves to tighten oversight of vaccine exports

As the public conflict between the European Commission and the British-Swedish pharma giant over apparent shortages in COVID-19 vaccine deliveries continues to heat up, the Commission has today implemented a new export transparency regime, allowing Member States to potentially block their exports. In recent days, Commission considerations of whether to institute greater oversight of which, and crucially how much, Covid-19 vaccines, manufactured in the EU, have raised considerable fears across the globe of an EU “export ban.” Under the new mechanism,...

Read more

Chapter News

Screening of websites for ‘greenwashing’: half of green claims lack evidence

Today, the European Commission and national consumer authorities released the results of a screening of websites (“sweep”), an exercise carried out each year to identify breaches of EU consumer law in online markets. This year, for the first time ever, the sweep focused on ‘greenwashing', the practice by which companies claim they are doing more for the environment than they actually are. The “sweep” analysed green online claims from various business sectors such as garments, cosmetics and household equipment....

Read more

Chapter News

IMF | Financial Perils in Check for Now, Eyes Turn to Risk of Market Correction

“The vaccines are here!”—the cry heard and welcomed the world over—has boosted hopes of a global economic recovery in 2021. Yet until vaccines are widely available, the market rally and the economic recovery rest on continued monetary and fiscal policy support. 'While there is for now no alternative to continued monetary policy support, there are legitimate concerns around excessive risk-taking and market exuberance.' Financial stability risks have been in check so far, but we cannot take this for granted. Prices for stocks, corporate bonds,...

Read more